Sponsored Content by Optibrium Ltd. Reviewed by Maria Osipova Sep 18 2025 insights from industry Matthew Segall CEO Optibrium   Discover how Optibrium is transforming early-stage drug discovery through AI-powered software, generative chemistry, and 3D modelling. In this interview, Matt Segall, CEO at Optibrium, shares insights into the company’s scientific innovations, user-focused design, and the future of computational drug discovery. Please introduce yourself and tell us about your